Xilio Development Inc (XLO)

Currency in USD
0.662
0.000(0.00%)
Closed·
0.703+0.041(+6.19%)
·
Unusual Post-Market activity
XLO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.6500.670
52 wk Range
0.6151.700
Key Statistics
Prev. Close
0.662
Open
0.662
Day's Range
0.65-0.67
52 wk Range
0.615-1.7
Volume
110.71K
Average Volume (3m)
633.91K
1-Year Change
-40.36%
Book Value / Share
-0.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XLO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.000
Upside
+202.11%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Xilio Development Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Xilio Development Company Profile

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company’s checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.

Compare XLO to Peers and Sector

Metrics to compare
XLO
Peers
Sector
Relationship
P/E Ratio
−0.6x−10.0x−0.6x
PEG Ratio
−0.03−0.220.00
Price/Book
−4.3x4.5x2.6x
Price / LTM Sales
1.1x65.0x3.2x
Upside (Analyst Target)
202.1%105.6%41.8%
Fair Value Upside
Unlock7.5%5.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.000
(+202.11% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Leerink Partners
Buy2.00+202.11%-New Coverage06/08/2025

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.11 / -0.05
Revenue / Forecast
19.07M / 16.48M
EPS Revisions
Last 90 days

People Also Watch

0.979
IPSC
+14.09%
1.4600
INHD
-7.59%
2.430
CMND
-6.18%
2.190
PRLD
-3.10%
3.17
STTK
+0.96%

FAQ

What Is the Xilio Development (XLO) Share Price Today?

The live Xilio Development share price today is 0.662

What Stock Exchange Does Xilio Development (XLO) Trade On?

Xilio Development is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Xilio Development?

The stock symbol (also called a 'ticker') for Xilio Development is "XLO."

What Is the Current Xilio Development Market Cap?

As of today, Xilio Development market capitalisation is 34.74M.

What Is Xilio Development's (XLO) Earnings Per Share (TTM)?

The Xilio Development EPS is currently -1.13 (Trailing Twelve Months).

When Is the Next Xilio Development Earnings Date?

Xilio Development's next earnings report will be released on 04 Mar 2026.

Is XLO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Xilio Development moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Xilio Development Stock Split?

Xilio Development has split 0 times. (See the XLO stock split history page for full effective split date and price information.)

How Many Employees Does Xilio Development Have?

Xilio Development has 64 employees.

What is the current trading status of Xilio Development (XLO)?

As of 24 Dec 2025, Xilio Development (XLO) is trading at a price of 0.662, with a previous close of 0.662. The stock has fluctuated within a day range of 0.650 to 0.670, while its 52-week range spans from 0.615 to 1.700.

What Is Xilio Development (XLO) Price Target According to Analysts?

The average 12-month price target for Xilio Development is USD2, with a high estimate of USD2 and a low estimate of USD2. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +202.11% Upside potential.

What Is the XLO After Hours Price?

XLO's last after hours stock price is 0.703, the stock has decreased by 0.041, or 6.190%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.